Supernus Pharmaceuticals, Inc. (SUPN)
48.22
-1.21
(-2.45%)
USD |
NASDAQ |
May 18, 15:30
Supernus Pharmaceuticals Profit Margin (Quarterly) : -1.10% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -18.92% |
| Johnson & Johnson | 21.75% |
| Amphastar Pharmaceuticals, Inc. | 3.75% |
| Assertio Holdings, Inc. | -189.8% |
| Eli Lilly & Co. | 37.36% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.75% |
| Return on Assets | -2.00% |
| Return on Invested Capital | -2.65% |
| Gross Profit Margin (Quarterly) | 76.15% |
| Operating Margin (Quarterly) | -3.58% |
| Return on Net Operating Assets | -3.09% |